Insider · CIK 0001214505

NICHOL GEOFFREY

Reports to the SEC for 3 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001214505

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-27	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,230 sh	—	—	1,230
2024-06-13	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-06-15	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,200 sh	—	—	8,200
2022-06-17	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2021-07-01	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,635 sh	—	—	6,635
2021-07-01	TPSTTempest Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,635 sh	—	—	6,635
2020-06-22	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2019-12-17	TPSTTempest Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2015-12-12	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Executive Vice President, R&D	FTax Payment	−4,384 sh	$8.68	−$38.1K	159,676
2015-12-11	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Executive Vice President, R&D	FTax Payment	−4,697 sh	$8.68	−$40.8K	164,060
2015-12-08	SGMOQSANGAMO THERAPEUTICS, INCA Award	Executive Vice President, R&D	AAward	+37.5K sh	—	—	175,646
2015-12-08	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Executive Vice President, R&D	AAward	+75K sh	—	—	75,000
2015-12-07	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Executive Vice President, R&D	FTax Payment	−6,889 sh	$9.69	−$66.8K	168,757
2014-12-15	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Executive Vice President, R&D	FTax Payment	−41.7K sh	$14.74	−$615K	138,146
2014-12-11	SGMOQSANGAMO THERAPEUTICS, INCA Award	Executive Vice President, R&D	AAward	+37.5K sh	—	—	179,889
2014-12-11	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Executive Vice President, R&D	AAward	+75K sh	—	—	75,000
2013-12-12	SGMOQSANGAMO THERAPEUTICS, INCA Award	Executive Vice President, R&D	AAward	+35K sh	—	—	165,000
2013-12-12	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Executive Vice President, R&D	FTax Payment	−22.6K sh	$12.12	−$274K	142,389
2013-12-12	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Executive Vice President, R&D	AAward	+70K sh	—	—	70,000
2012-12-06	SGMOQSANGAMO THERAPEUTICS, INCA Award	Executive Vice President, R&D	AAward	+55K sh	—	—	130,000
2012-12-06	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)A Award	Executive Vice President, R&D	AAward	+110K sh	—	—	110,000
2011-12-08	SGMOQSANGAMO THERAPEUTICS, INCA Award	Executive Vice President, R&D	AAward	+75K sh	—	—	75,000
2011-07-11	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Executive Vice President, R&D	AAward	+300K sh	—	—	300,000
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−55.9K sh	$16.00	−$894K	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−17.8K sh	$16.00	−$285K	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−10.1K sh	$16.00	−$162K	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−200K sh	$16.00	−$3.2M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−144K sh	$16.00	−$2.31M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−167K sh	$16.00	−$2.67M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−240K sh	$16.00	−$3.84M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−110K sh	$16.00	−$1.76M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−120K sh	$16.00	−$1.92M	0
2009-09-01	MEDAREX INCStock Option (Right to Buy)D Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−120K sh	$16.00	−$1.92M	0
2009-09-01	MEDAREX INCRestricted Stock UnitsD Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−40K sh	$16.00	−$640K	0
2009-09-01	MEDAREX INCRestricted Stock UnitsD Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−40K sh	$16.00	−$640K	0
2009-09-01	MEDAREX INCRestricte Stock UnitsD Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−9,010 sh	$16.00	−$144K	0
2009-09-01	MEDAREX INCRestricted Stock UnitsD Disposition to Issuer	Senior Vice President	DDisposition to Issuer	−17K sh	$16.00	−$272K	0
2009-08-27	MEDAREX INCU Disposition from Tender	Senior Vice President	UDisposition from Tender	−35.9K sh	$16.00	−$575K	0
2009-08-27	MEDAREX INCU Disposition from Tender	Senior Vice President	UDisposition from Tender	−15.9K sh	$16.00	−$255K	0
2009-03-13	MEDAREX INCRestricted Stock UnitsA Award	Senior Vice President	AAward	+9,719.22 sh	—	—	9,719.22
2009-03-05	MEDAREX INCStock Option (Right to Buy)A Award	Senior Vice President	AAward	+120K sh	—	—	120,000
2009-03-05	MEDAREX INCRestricted Stock UnitsA Award	Senior Vice President	AAward	+40K sh	—	—	40,000
2009-02-24	MEDAREX INCM Exercise/Conversion	Senior Vice President	MExercise/Conversion	+5,926 sh	—	—	74,484
2009-02-24	MEDAREX INCRestricted Stock UnitsM Exercise/Conversion	Senior Vice President	MExercise/Conversion	−5,926 sh	—	—	0
2007-05-31	MEDAREX INCStock Options (Right to Buy)A Award	Senior Vice President	AAward	+30K sh	—	—	30,000
2005-02-08	MEDAREX INCPhantom Stock UnitsA Award	Senior Vice President	AAward	+17K sh	—	—	16,986
2004-07-26	MEDAREX INCStock Options (Right to Buy)A Award	Senior Vice President	AAward	+185K sh	—	—	185,000
2004-03-02	MEDAREX INCPhantom Stock UnitsA Award	Senior Vice President	AAward	+9,010 sh	—	—	9,010
2003-10-14	MEDAREX INCStock Options (Right to Buy)A Award	Senior Vice President	AAward	+200K sh	—	—	200,000
2003-10-14	MEDAREX INCStock Options (Right to Buy)A Award	Senior Vice President	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Jan 284
NICHOL GEOFFREY0001214505-26-000003
SEC(opens sec.gov)
Jun 144
NICHOL GEOFFREY0001415889-24-017011
SEC(opens sec.gov)
Jun 204
NICHOL GEOFFREY0001209191-23-038448
SEC(opens sec.gov)
Jun 224
NICHOL GEOFFREY0001179110-22-003380
SEC(opens sec.gov)
Sep 204/A
NICHOL GEOFFREY0001179110-21-008869
SEC(opens sec.gov)
Jul 64
NICHOL GEOFFREY0001140361-21-023540
SEC(opens sec.gov)
Jun 234
NICHOL GEOFFREY0001544227-20-000030
SEC(opens sec.gov)
Dec 194
NICHOL GEOFFREY0001209191-19-061358
SEC(opens sec.gov)
Dec 154
SANGAMO BIOSCIENCES INC0001140361-15-044641
SEC(opens sec.gov)
Dec 94
SANGAMO BIOSCIENCES INC0001140361-15-044027
SEC(opens sec.gov)
Dec 154
SANGAMO BIOSCIENCES INC0001209191-14-075579
SEC(opens sec.gov)
Dec 134
SANGAMO BIOSCIENCES INC0001209191-13-056977
SEC(opens sec.gov)
Dec 104
NICHOL GEOFFREY0001181431-12-063542
SEC(opens sec.gov)

Companies

Address

C/O TEMPEST THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400

BRISBANE, CA, 94005